8-K: Bausch Health Shareholders Elect Directors, Approve Compensation
Annual Meeting Results
Bausch Health Companies Inc. held its Annual Meeting of Shareholders on May 19, 2026, where shareholders elected directors, approved executive compensation on an advisory basis, and appointed PricewaterhouseCoopers LLP as auditors.
Summary
- Bausch Health Companies Inc. conducted its Annual Meeting of Shareholders on May 19, 2026.
- Shareholders elected ten individuals to the Board of Directors, with Eiry W. Roberts, M.D. being a newly elected director.
- The compensation of the Named Executive Officers was approved on a non-binding advisory basis.
- PricewaterhouseCoopers LLP was appointed as the independent registered public accounting firm for the Company until the 2027 Annual Meeting of Shareholders.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports on routine annual meeting outcomes without significant new financial information or strategic shifts.
Positives
- Successful election of all nominated directors, indicating shareholder confidence in the board.
- Approval of executive compensation on an advisory basis, suggesting general shareholder agreement with the compensation structure.
- Appointment of PricewaterhouseCoopers LLP, a reputable accounting firm, as auditors.
Future Outlook
The filing does not contain specific forward-looking statements or guidance beyond the appointment of auditors and directors until the 2027 Annual Meeting.
Industry Context
StockSavvy.ai notes that the routine nature of this 8-K filing, focusing on shareholder votes for director elections, executive compensation, and auditor appointments, is typical for publicly traded companies and reflects standard corporate governance practices.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | N/A | Eiry W. Roberts, M.D. | 2026-05-19 | Elected by shareholders at the Annual Meeting. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Election | Election of ten directors to the Board of Directors. | 2026-05-19 | Maintains board continuity and structure. |
| Executive Compensation Approval | Advisory vote on the compensation of Named Executive Officers. | 2026-05-19 | Indicates shareholder support for current executive compensation policies. |
| Auditor Appointment | Appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm. | 2026-05-19 | Ensures independent financial oversight and audit. |
Stakeholder Impact
- Shareholders: Direct impact through voting on director elections and executive compensation, and indirect impact through auditor appointment for financial oversight.
- Management: Executive compensation approved on an advisory basis, reinforcing current compensation structures.
- Auditors: PricewaterhouseCoopers LLP appointed to provide independent audit services.
Next Steps
- Directors elected will serve until the close of the 2027 Annual Meeting of Shareholders.
- PricewaterhouseCoopers LLP will serve as the independent registered public accounting firm until the close of the 2027 Annual Meeting of Shareholders.
- The Board of Directors is authorized to fix the remuneration of the auditors.
Key Dates
| Date | Description |
|---|---|
| 2026-05-19 | Date of the Annual Meeting of Shareholders and the earliest event reported. |
| 2027-05-19 | Term end date for elected directors and the period for which PricewaterhouseCoopers LLP is appointed as auditors. |
Keywords
Bausch Health, Annual Meeting, Shareholder Vote, Board of Directors, Executive Compensation, Auditors, PricewaterhouseCoopers LLP, Form 8-K
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.